Real-World Analysis Evaluating Treatment Eligibility and Outcomes in Patients With AML Receiving Intensive Chemotherapy: Insights From an Underrepresented Population
PURPOSEOver the past decade, there have been significant advancements in the treatment of AML. However, similar progress has not been observed in India, with induction mortality rates surpassing those in high-income countries. Our patient population also differs significantly from those in clinical...
Saved in:
| Main Authors: | Hasmukh Jain, Thomas Eipe, Alok Shetty, Lingaraj Nayak, Bhausaheb Pandurang Bagal, Neha Sharma, Akash Pawar, Manju Sengar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society of Clinical Oncology
2025-04-01
|
| Series: | JCO Global Oncology |
| Online Access: | https://ascopubs.org/doi/10.1200/GO-24-00482 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary central nervous system lymphoma: Comprehension of cell-of-origin subtypes
by: Shruti Rao, et al.
Published: (2023-07-01) -
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy
by: Prashant Ramesh Tembhare, et al.
Published: (2020-05-01) -
Chemotherapy effectiveness in trial-underrepresented groups with early breast cancer: A retrospective cohort study.
by: Ewan Gray, et al.
Published: (2019-12-01) -
Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium
by: Akhil Rajendra, et al.
Published: (2025-03-01) -
Distributing Knowledge Creation to Include Underrepresented Populations
by: Richard F. Heller, et al.
Published: (2025-05-01)